Press Releases 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Eagle Pharmaceuticals Appoints Former FDA Official and Public Health Expert Dr. Luciana Borio to its Board of Directors 5/3/21 Eagle Pharmaceuticals Announces TREAKISYM (bendamustine) Ready-to-Dilute (“RTD”) Formulation, in Combination with Rituximab for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma Receives PMDA Approval in Japan 4/30/21 Eagle Pharmaceuticals to Host First Quarter 2021 Financial Results on May 10, 2021 4/29/21 Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Results and Provides Pipeline Review 3/2/21 Eagle Pharmaceuticals to Host Fourth Quarter and Full Year 2020 Financial Results and Pipeline Review on March 2, 2021 2/22/21 Eagle Pharmaceuticals Receives Additional FDA Questions Regarding Vasopressin; Court Date Set for July 7, 2021 in Vasopressin Trial 2/2/21 Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed 2/1/21 Eagle Pharmaceuticals Announces Update in Vasopressin Trial; Trial Date Postponed from January 11, 2021 to February 1, 2021 to Protect Against COVID-19 Concerns 1/11/21 Eagle Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 1/4/21 Pagination First page Previous page Page 1 Page 2 Current page 3
